Neurochemists explore the chemical processes that occur in the brain, focusing on how neurotransmitters, hormones, and other chemicals influence brain function and behavior. They investigate how these chemicals are synthesized, released, and regulated within the nervous system, examining their roles in mood regulation, cognition, and motor control. Neurochemistry plays a critical role in understanding disorders such as depression, anxiety, schizophrenia, and Parkinson's disease, all of which involve imbalances in brain chemistry. Neurochemists also study how drugs, both therapeutic and recreational, affect the brain’s chemical environment and contribute to neurological and psychiatric conditions. Their research provides valuable insights into developing more effective medications, targeting specific neurotransmitter systems to treat conditions like epilepsy, bipolar disorder, and addiction. Furthermore, neurochemists study the molecular mechanisms of neurodegenerative diseases, such as Alzheimer's, where protein misfolding and deposition contribute to cognitive decline. Their work in neurochemical signaling and receptor function has significant implications for drug development, as they aim to create more selective, personalized treatments with fewer side effects. Additionally, neurochemists are involved in studying the impact of diet and lifestyle on brain chemistry, which can influence brain aging, cognitive decline, and overall mental health.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States